XML 30 R19.htm IDEA: XBRL DOCUMENT v3.7.0.1

Purchase of LAT Pharma (Tables)

12 Months Ended

Jun. 30, 2017

Purchase Of Lat Pharma Tables

Schedule of Assets and Liabilities of LAT Pharma, Inc.

The assets and liabilities of LAT Pharma, Inc. were recorded at their respective fair values as of the closing date of the Merger Agreement, and the following table summarizes these values based on the balance sheet at April 11, 2016. 

$	2,303,682			Assets Purchased
	260,193			Liabilities Assumed
	2,043,489			Net Assets Purchased
	2,389,200			Purchase Price
$	345,711			Goodwill from Purchase

Intangible asset detail 

$	2,293,770			Intangible Intellectual Property
	345,711			Goodwill
$	2,639,481			Intangible Asset from Purchase

X

- References

No definition available.

+ Details

Name:	bivi_DisclosurePurchaseOfLatPharmaTablesAbstract
Namespace Prefix:	bivi_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of a material business combination completed during the period, including background, timing, and recognized assets and liabilities. This table does not include leveraged buyouts.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463

+ Details

Name:	us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration